Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03639285 · ClinicalTrials.gov registry record
Natural History, Diagnosis, and Outcomes for Leukodystrophies
A clinical trial of Leukodystrophy, sponsored by University of Utah.
- Recruiting
- Registry status
- 600
- Enrollment target
- 1
- Study location
NCT03639285: Recruiting study of Leukodystrophy, sponsored by University of Utah.
NCT03639285 is a study of Leukodystrophy that is actively recruiting participants, run by University of Utah. The registered enrollment target is 600 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03639285, a study of Leukodystrophy, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 1
- Study location
Study Summary
The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies.
Primary Outcome
Determine rates of morbidity
Conditions Studied
Study Locations (1)
Utah
- Primary Children's Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2007-01-19 |
| Est. Completion | 2050-12-31 |
What NCT03639285 shows while recruiting
NCT03639285 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Leukodystrophy appearing as the primary indexed condition, and to 0 interventions.
NCT03639285 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT03639285 about?
NCT03639285 is a clinical study titled "Natural History, Diagnosis, and Outcomes for Leukodystrophies". The goals of this protocol is to diagnose, care for, and understand the clinical histories and outcomes of people with leukodystrophies.
What is the current status of trial NCT03639285?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2007-01-19. Estimated completion is 2050-12-31.
What conditions does trial NCT03639285 study?
This clinical trial studies the following conditions: Leukodystrophy.
Who is sponsoring clinical trial NCT03639285?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03639285 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukodystrophy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI